Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Mr. Pink Collections, LLC
WARNING LETTER
•Mr. Pink Collections, LLC•November 25, 2019

FDA WARNING_LETTER - Mr. Pink Collections, LLC - November 25, 2019

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

On November 22, 2019, the FDA issued a Warning Letter to Mr. Hu regarding products sold on www.mrpinkcbd.com, www.facebook.com/MrPinkCBD/, www.instagram.com/mrpinkcbd/, and a YouTube video. The FDA determined that "CBD Oil Drops," "CBD Gummies," "CBD Vape Pen," and "Mr. Pink Natural CBD Oil for Pets" (also "Vegan Bacon Flavored Pet CBD Oil"), promoted as containing CBD, violate the Federal Food, Drug, and Cosmetic Act (FD&C Act).

The "CBD Oil Drops," "CBD Gummies," and "CBD Vape Pen" are deemed unapproved new drugs under sections 505(a) and 301(d), and misbranded drugs under section 502(f)(1) of the FD&C Act, due to therapeutic claims establishing drug intent. These products are not generally recognized as safe and effective, and lack FDA approval or adequate directions for use. Furthermore, CBD products are excluded from the dietary supplement definition under section 201(ff) because CBD is an active ingredient in an approved drug (Epidiolex) and subject to substantial clinical investigations.

The "CBD Gummies" product, if marketed as a conventional human food, is prohibited under section 301(ll) as it contains a substance (CBD) that is an active ingredient in an approved drug and is not

Company
Mr. Pink Collections, LLC
Inspection Date
November 25, 2019
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Donald D. Ashley (Director)
  • Eric M. Nelson (Director - Division of Compliance)
  • William A. Correll (Director)
Open in Dashboard

ID · 89692630-e338-4b44-a4bb-66f06ad0e638

Violation Codes10
21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 352(f)(1)21 U.S.C. 360b(a)21 U.S.C. 351(a)(5)21 U.S.C. 321(ff)21 U.S.C. 321(ff)(3)(B)(i)21 U.S.C. 321(ff)(3)(B)(ii)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.